References
- Mehta PA, Dubrey SW, McIntyre HF, et al. Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail (2008);10:1108-16
- Ryden-Bergsten T, Andersson F. The health care costs of heart failure in Sweden. J Intern Med (1999);246:275-84
- Somaratne JB, Berry C, McMurray JJ, et al. The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. Eur J Heart Fail (2009);11:855-62
- Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol (2004);43:317-27
- Cline CM, Boman K, Holst M, et al. The management of heart failure in Sweden. Eur J Heart Fail (2002);4:373-6
- Malmberg I, Persson U. [Primary health care costs in connection with heart failure surveyed: increased use of ACE inhibitors would be beneficial]. Lakartidningen (2000);97:2465-70
- Persson H, Malmqvist K, Carlsson A, et al. [More and more persons suffer from heart failure. Better treatment and information are necessary]. Lakartidningen (1994);91:3251-4
- Agvall B, Borgquist L, Foldevi M, et al. Cost of heart failure in Swedish primary healthcare. Scand J Prim Health Care (2005);23:227-32
- Schwinger R. Pathophysiology of heart failure. Clin Res Cardiol Suppl (2010);4:16-20
- Jonsson A, Edner M, Alehagen U, et al. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail (2010);12:25–31
- MacKenzie E, Smith A, Angus N, et al. Mixed-method exploratory study of general practitioner and nurse perceptions of a new community based nurse-led heart failure service. Rural Remote Health (2010);10:1510
- Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail (2002);4:361-71
- Ringborg A, Yin DD, Martinell M, et al. The impact of acute myocardial infraction and stroke on health care costs in patients with type 2 diabetes in Sweden. Eur J Cardiovasc Prev Rehabil (2009);16:576-82
- Kjeldsen SE, Stalhammar J, Hasvold P, et al. Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. J Hum Hypertens (2010);24:263–73
- Carlsson A, Borgström F, Stålhammar J, et al. Cost of care for patients treated with lipid-lowering drugs. Pharmacoeconomics (2004);22(3 Suppl):25-35
- Ringborg A, Martinell M, Stålhammar J, et al. Resource use and costs of type 2 diabetes in Sweden – estimates from population-based register data. Int J Clin Pract (2008);62:708-16
- Ringborg A, Yin DD, Martinell M, et al. The impact of acute myocardial infarction and stroke on health care costs in the patients with type 2 diabetes in Sweden. Eur J Cardiovasc Prev Rehabil (2009);16:576-82
- Kjeldsen SE, Stålhammar J, Hasvold P, et al. Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension. J Human Hypertension (2010);24:263-73
- Henriksson M, Russell D, Bodegard J, et al. Health-care costs of losartan and candesartan in the primary treatment of hypertension. J Hum Hypertens (2010);25:130-6
- Agvall B, Borgquist L, Foldevi M, et al. Cost of heart failure in Swedish primary healthcare. Scand J Prim Health Care (2005);23:227-32
- Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail (2008);10:933-89
- Heart Failure Performance Measurement Set: American College of Cardiology Foundation (ACCF); American Heart Association (AHA); Physician Consortium for Performance ImprovementR (PCPI™); January 2011. Available at <http://www.ama-assn.org/ama1/pub/upload/mm/pcpi/hfset-12-5.pdf> [Last accessed May 2012]
- Andersson B, Kjork E, Brunlof G. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment. Int J Cardiol (2005);104:257-63